Researchers explore the effect psychedelics have on the brain and how they are effective at treating depression.
A preclinical drug that inhibits the kinase enzyme Cdk5 may have the potential to treat depression, brain injuries, and disorders associated with cognitive impairment.
Using psychiatric medications to treat mental health disorders in children and adolescents does not increase the risk of developing substance use disorders later in life. In fact, pharmacological interventions reduce the risk of developing SUD for those with MDD, ADHD, and psychotic disorders.
Researchers have identified six predictors that may help determine the correct amount of lithium to treat a patient with bipolar disorder.
Mouse study reveals how depression and chronic stress can have an impact on cholesterol-lowering medications and influence the risk of heart disease.
Overall, people who used antidepressants to manage depression long-term did not have a better quality of physical or mental health than those with depression who did not use prescription medication to manage their symptoms.
Fetal exposure to antidepressants or antiepileptic medications may affect the development of newborn brain networks.
Legalized marijuana for recreational use reduces the demand for prescription medications, a new study reveals. Researchers found the volume of medical prescriptions for pain, sleep disorders, anxiety, and some neurological conditions declined significantly when recreational marijuana was legalized.
NYX-783, a newly discovered drug, helps modulate NMDA receptor function in neurons. The drug appears to be effective at suppressing the return of PTSD symptoms in rodent models.